Glaxosmithkline Pakistan Limited · PSX:GLAXO
Glaxosmithkline Pakistan — Investor Presentation (2020)
22 slides from Glaxosmithkline Pakistan's investor presentation, 2020
Slide 1: Corporate Briefing Session 2020
Corporate Briefing Session 2020 GlaxoSmithKline Pakistan Limited
Slide 2: Agenda
Agenda Company’s Overview COVID-19 GSK’s response PSX Corporate Briefing Financial outline Questions & Answers Conclusion of Session 2
Slide 3: Company's Overview
Company’s Overview
Slide 4: Our Local Footprint
Our Local Footprint Registered Office: 35-Dockyard Road, West Wharf, Karachi Sales Offices: Karachi , Lahore, Multan , Islamabad , Peshawar Head Office at Wharf Office Factories in Pakistan F-268 West Wharf Korangi 4
Slide 5: GSK Pakistan Demographics
GSK Pakistan Demographics Number of Employees 1,957 Pharma Commercial 830 Pharma Supply Chain 987 Global Support Functions 140 GSK Pakistan Gender Diversity 18% Females Average Employee Age 40 Years Average Employee Experience 13 Years 5
Slide 6: Board of Directors and Key changes
Board of Directors and Key changes Mr. Dmytro Oliinyk Ms. Erum Shakir Rahim Mr. Abdul Samad Ms. Maheen Rahman Mr. Muneer Kamal Mr. Mehmood Mr. Mark Dawson Chairman Chief Executive Officer Chief Financial Officer Independent Director Independent Director Mandviwalla Non-Executive Director Non-Executi
Slide 7: Our Purpose, Goal and Strategy
Our Purpose, Goal and Strategy Purpose To help people do more, feel better, live longer Goal To be one of the world’s most innovative, best performing and trusted healthcare companies Strategy Innovation Performance Trust To invest in scientific and We aim to achieve long-term We commit to ensuring
Slide 8: Our Values & Expectations are at the Heart of Everything We Do
Our Values & Expectations are at the Heart of Everything We Do Patient focus 8
Slide 9: GSK Pakistan: A Legacy of Success
GSK Pakistan: A Legacy of Success #1 on MAT in Value on MAT in Volume #2 on MAT in Rx - 144m Rx 2 Brands in industry top 10 in Value 3 manufacturing sites; 400m units in a year 4 Brands in industry top 10 in Volume Listed entity in Pakistan stock exchange since 1951 2 Brands in industry top 10 in Rx
Slide 10: Key Therapy areas and Brands in Pakistan
Key Therapy areas and Brands in Pakistan Antibiotic Dermatology Respiratory Analgesics Vaccines 10
Slide 11: Successful Implementation of One ERP (SAP)
Successful Implementation of One ERP (SAP) – Pakistan was part of Cluster 1 deployment. – Implementation was successfully achieved – Go Live October 05th with record completion within 9 months – 100% remote deployment; go-live was on time despite pandemic – Model Office Sessions were conducted with
Slide 12: Best Corporate & Sustainability Report 2019 Award
Best Corporate & Sustainability Report 2019 Award 1st GlaxoSmithKline Pakistan Limited 2nd Abbott Laboratories (Pakistan) Limited 3rd AGP Limited 4th GSK Consumer Healthcare Pakistan Limited 5th Sanofi-Aventis Pakistan Limited 12
Slide 13: COVID-19: GSK's response
COVID-19: GSK’s response
Slide 14: Response to COVID
Response to COVID 3 Pronged strategy People Business Support continuity • Prioritizing people health and safety • Regular situation update and review by • Online tools for through strict enforcement of Countryduring IMT Employee Assistance COVID safety measures. Maximum Initiatives COVID Wave 2 Read
Slide 15: GSK's Global COVID-19 solutions key facts
GSK’s Global COVID-19 solutions key facts.. Using our science, technology, portfolio and resources to support development of products for prevention and treatment of COVID-19 and the overall global response Our Science and Technology… 100 million adjuvant already delivered Medicago + GSK Our primary
Slide 16: Financial Outline
Financial Outline
Slide 17: Financial Performance
Financial Performance Sales for the year (Rs. in bn) • Accelerating pharma business through 31.9 increased HCP coverage, introducing multi 29.9 28.7 channel engagement and trade channel 25.1 investment 24.1 • The Company delivered operating profit Rs. 3.8 bn for nine months. • Healthy dividend payou
Slide 18: Key Financial Highlights
KEY FINANCIAL HIGHLIGHTS September 2020 Net Sales * Profit before Earning per Gross profit Gross margin 26.6 Billion tax share 6.03 billion 22.7% 3.8 Billion Rs. 7.44 September 2019 Profit before Earning per Net Sales Gross profit Gross margin tax share 25.8 Billion 5.6 billion 21.6% 2.9 Billion Rs.
Slide 19: Key Financial Ratios
KEY FINANCIAL RATIOS Balance Sheet Ratios September 30, September 30, 2020 2019 Return on equity 14% 12% Current Ratio 1.97 1.84 Inventory days 118 139 Receivables days 19 18 Payable days 36 44 19
Slide 20: Outlook and Challenges
Outlook and Challenges At a glance The environment is volatile and uncertain due to Wave 2 and smart lockdown situation. Regular Issue Management Team meeting to closely monitor the situation and initiate remedial measures F2F interaction with Health Care Professional is a challenge. Our field force
Slide 21: Questions & Answers
Questions & Answers
Slide 22: Conclusion of session Thank You
Conclusion of session Thank You
GlaxoSmithKline Pakistan — Investor Presentation (2020) on 6ix